Eli Lilly to acquire Curevo, Limmatech, vaccine company, WSJ reports.
Eli Lilly to acquire Curevo, Limmatech, and a vaccine company, according to the Wall Street Journal.
Quick reaction
One tap helps tune what we surface next.
Reader discussion
Public commentsNo comments yet. Start the discussion around this signal.
Follow this signal
Get updates on this story
We will email you if this changes materially. No spam. Daily brief optional.
Map context
See this on the live map
Keep the story in context with nearby live signals, countries, and category movement.
Related coverage
More story pages
Quantinuum files for $1.05B US IPO, targets $12.7B valuation at top of range, Bloomberg reports.
Quantinuum is seeking to raise $1.05B in its US IPO, marketing about 21 million shares at $45-$50 each, implying a $12.7B valuation at the top of the range, according to Bloomberg's @csreinicke.
Xiaomi Q1 revenue falls 11% to $14.6B, first decline in 3 years; net income drops 57% to $695M amid memory price surge (Bloomberg)
Xiaomi reports Q1 revenue down 11% YoY to approximately $14.6 billion, its first quarterly decline in three years, and net income down 57% to $695 million amid a global memory price jump.
SpaceX IPO prospectus warns Tesla investors of massive cash burn from Musk's AI ambitions, highlights conflict risk
Bloomberg Opinion reports that SpaceX's IPO prospectus warns Tesla investors about the massive cash burn from Elon Musk's AI ambitions and notes potential for conflict risk of galactic proportions.
Momentum trading strategy posts best returns in decades, Bloomberg data shows.
A popular equity trading strategy — buying stocks that are rallying — is generating its best returns in decades, according to Bloomberg.
More live signals
Continue with the live feed.
The fastest nearby updates load from the public feed, not the enriched story endpoint.